NextGen LiquiCore CTC Comprehensive is an advanced liquid biopsy test designed to detect and analyze circulating tumor cells (CTCs) from a simple blood sample. This non-invasive test assists in cancer diagnosis, monitoring treatment response, and assessing risk of recurrence through detailed cellular and molecular profiling. It offers real-time insight into tumor behavior and therapy resistance without requiring tissue biopsy. Metropolis Healthcare performs this test using high-precision molecular technology to support personalized cancer management.
Price:
Rs. 20,000.00
Sample Type: K2EDTA Blood
Fasting Not Required
Notes: N8195
Frequently Asked Questions (FAQ's):
What does the NextGen LiquiCore CTC Comprehensive test include?
This test includes detection, counting, and molecular analysis of circulating tumor cells for detailed cancer evaluation.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced cell-enrichment and genomic profiling technologies to accurately analyze tumor cells present in the blood.
Who should take this test?
Patients diagnosed with solid tumors or undergoing cancer treatment where non-invasive disease monitoring is required.
What are the benefits of this test at Metropolis Healthcare?
It enables real-time tracking of cancer progression, therapy response, and emerging resistance markers, helping personalize treatment decisions.
Is a tissue biopsy required along with this test?
No, this liquid biopsy can provide meaningful tumor insights using only a blood sample collected at Metropolis Healthcare.
What type of sample is needed for the test?
A peripheral blood sample is required for circulating tumor cell evaluation.
How long does Metropolis Healthcare take to provide results?
Reports are usually available within 10–14 working days depending on complexity and analysis requirements.
Does Metropolis Healthcare offer clinical guidance with the results?
Yes, expert oncopathologist interpretation and clinical support are provided for better understanding and treatment planning